ADA 2017

By Mark Harmel from

Exercise is really tough to manage with type 1 diabetes; will the development of the artificial pancreas (AP) make it any easier? With the varied glucose impact of different exercise types from a long aerobic run to anaerobic weight-lighting, the impact all of these profile types would need to be programmed into the algorithm. There are even wide variations among individuals from day to day, so there may be some benefit from the use of a dual hormone insulin/glucagon pump for people who exercise.

In type 1 patients without an AP pump, injection of a mini-dose of glucagon, or careful post-exercise treatment of hyperglycemia, can also be useful.

Michael C. Riddell, PhD. is Professor in the School of Kinesiology & Health Science at York University and the the lead author of Exercise management in type 1 diabetes: a consensus statement

Original article available at